80 results
Page 2 of 4
424B5
pwjj4r
16 Mar 22
Prospectus supplement for primary offering
8:00am
8-K
EX-10.1
6y4zq5x
7 Feb 22
Axcella Therapeutics Announces Appointment of New Chief Financial Officer
4:00pm
8-K
EX-10.1
7bmd4k6wcp9a8zt7nz
7 Dec 21
Departure of Directors or Certain Officers
6:15am
8-K
EX-10.1
wvzuzi vg5cdx
7 Sep 21
Entry into a Material Definitive Agreement
4:16pm
8-K
EX-10.1
afutfm
3 Mar 21
Axcella Announces Alison D. Schecter, M.D., as President of R&D
5:26pm
S-3
EX-4.4
txk 5itrk
5 Jun 20
Shelf registration
5:02pm
S-3
7fb17g6 6bs4
5 Jun 20
Shelf registration
5:02pm
S-3
EX-4.3
80ywc3te5xm5azt fv2
5 Jun 20
Shelf registration
5:02pm
S-3
EX-1.2
zwryhggvl3moae6rhs2
5 Jun 20
Shelf registration
5:02pm
424B4
8n17bdp5ctw1bj8o39zh
14 May 20
Prospectus supplement with pricing info
5:15pm